Litigation

Recent Posts

$4 Million Awarded In 1st Pa. Trial Alleging Birth Defect From Topamax Epilepsy Drug
Posted on 31 Oct 2013 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania jury on Oct. 30 found that Janssen Pharmaceuticals Inc. failed to warn about the risk of birth defects from its Topamax epilepsy drug and awarded the injured minor $4 million in damages (April Czimmer... Read More

Tags: drugs , Pennsylvania , f birth defects , Topamax , April Czimmer , epilepsy drug , Litigation , Janssen Pharmaceuticals Inc. , et al. v. Ortho-McNeil-Janssen Pharmaceutica

Johnson & Johnson, 2 Units Plead Guilty, Pay $2.2 Billion In Criminal, Civil Penalties
Posted on 4 Nov 2013 by Tom Moylan

WASHINGTON, D.C. — (Mealey’s) Two Johnson & Johnson subsidiaries have pleaded guilty, and the parent company and two subsidiaries will pay $2.2 billion in criminal fines, civil penalties and forfeitures in one criminal and several civil... Read More

Tags: drugs , Medicare , off-label marketing , Risperdal , Natrecor , Medicaid , Litigation , Invega , United States of America v. Janssen Pharmaceuticals , Janssen Pharmaceuticals Inc. , Scios Inc. , diabetes , Johnson & Johnson , antipsychotic drug , U.S. Justice Department